138 related articles for article (PubMed ID: 2467379)
21. TM5275 prolongs secreted tissue plasminogen activator retention and enhances fibrinolysis on vascular endothelial cells.
Yasui H; Suzuki Y; Sano H; Suda T; Chida K; Dan T; Miyata T; Urano T
Thromb Res; 2013 Jul; 132(1):100-5. PubMed ID: 23611258
[TBL] [Abstract][Full Text] [Related]
22. Binding of tissue plasminogen activator to human endothelial cells. Importance of the B-chain as a ligand.
Cheng XF; Bäck O; Nilsson TK; Nylander Lundqvist E; Pohl G; Wallén P
Biochem J; 1992 Oct; 287 ( Pt 2)(Pt 2):407-13. PubMed ID: 1332673
[TBL] [Abstract][Full Text] [Related]
23. Enzyme secretion by human endothelial cells infected with Rickettsia conorii.
Raoult D; Drancourt AM; Ardissone JP
Acta Virol; 1987 Aug; 31(4):352-6. PubMed ID: 2892385
[TBL] [Abstract][Full Text] [Related]
24. Hormonal regulation of tissue-type plasminogen activator and plasminogen activator inhibitor type-1 in cultured monkey Sertoli cells.
Liu YX; Liu K; Zhou HM; Du Q; Hu ZY; Zou RJ
Hum Reprod; 1995 Mar; 10(3):719-27. PubMed ID: 7540182
[TBL] [Abstract][Full Text] [Related]
25. The effect of heparin and other glycosaminoglycans on levels of tissue plasminogen activator and plasminogen activator inhibitor in cultured human umbilical vein endothelial cells.
Marsh NA; Minter AJ; Chesterman CN
Blood Coagul Fibrinolysis; 1990 Jun; 1(2):133-8. PubMed ID: 1966669
[TBL] [Abstract][Full Text] [Related]
26. Induction of synthesis of plasminogen activator inhibitor type-1 by tissue-type plasminogen activator in human hepatic and endothelial cells.
Fujii S; Lucore CL; Hopkins WE; Billadello JJ; Sobel BE
Thromb Haemost; 1990 Nov; 64(3):412-9. PubMed ID: 2128971
[TBL] [Abstract][Full Text] [Related]
27. Effects of two complex hemodynamic stimulation profiles on hemostatic genes in a vessel-like environment.
Bergh N; Ulfhammer E; Karlsson L; Jern S
Endothelium; 2008; 15(5-6):231-8. PubMed ID: 19065314
[TBL] [Abstract][Full Text] [Related]
28. Enhanced secretion of tissue plasminogen activator by simultaneous use of retinoic acid and ascorbic acid from tissue cultured gastroepiploic artery.
Yoshino A; Suzuki K; Urano T; Aoki K; Takada Y; Kazui T; Takada A
Life Sci; 2002 Feb; 70(12):1461-70. PubMed ID: 11883720
[TBL] [Abstract][Full Text] [Related]
29. Tissue-plasminogen activator stimulates endothelial cell migration in wound assays.
Inyang AL; Tobelem G
Biochem Biophys Res Commun; 1990 Sep; 171(3):1326-32. PubMed ID: 2121140
[TBL] [Abstract][Full Text] [Related]
30. Adenosine 3':5'-cyclic monophosphate induces regulated secretion of tissue-type plasminogen activator and von Willebrand factor from cultured human endothelial cells.
Hegeman RJ; van den Eijnden-Schrauwen Y; Emeis JJ
Thromb Haemost; 1998 Apr; 79(4):853-8. PubMed ID: 9569204
[TBL] [Abstract][Full Text] [Related]
31. Sesamol regulates plasminogen activator gene expression in cultured endothelial cells: a potential effect on the fibrinolytic system.
Chen PR; Lee CC; Chang H; Tsai CE
J Nutr Biochem; 2005 Jan; 16(1):59-64. PubMed ID: 15629242
[TBL] [Abstract][Full Text] [Related]
32. A monoclonal antibody that does not recognize tissue-type plasminogen activator bound to its naturally occurring inhibitor.
Schleef RR; Wagner NV; Sinha M; Loskutoff DJ
Thromb Haemost; 1986 Dec; 56(3):328-32. PubMed ID: 2436333
[TBL] [Abstract][Full Text] [Related]
33. Binding of tissue plasminogen activator to human aortic endothelial cells.
Sanzo MA; Howard SC; Wittwer AJ; Cochrane HM
Biochem J; 1990 Jul; 269(2):475-82. PubMed ID: 2117440
[TBL] [Abstract][Full Text] [Related]
34. Platelet-derived growth factor B chain promoter contains a cis-acting fluid shear-stress-responsive element.
Resnick N; Collins T; Atkinson W; Bonthron DT; Dewey CF; Gimbrone MA
Proc Natl Acad Sci U S A; 1993 May; 90(10):4591-5. PubMed ID: 8506304
[TBL] [Abstract][Full Text] [Related]
35. Tissue plasminogen activator induced by dengue virus infection of human endothelial cells.
Huang YH; Lei HY; Liu HS; Lin YS; Chen SH; Liu CC; Yeh TM
J Med Virol; 2003 Aug; 70(4):610-6. PubMed ID: 12794725
[TBL] [Abstract][Full Text] [Related]
36. Interaction of vasculotropin/vascular endothelial cell growth factor with human umbilical vein endothelial cells: binding, internalization, degradation, and biological effects.
Bikfalvi A; Sauzeau C; Moukadiri H; Maclouf J; Busso N; Bryckaert M; Plouet J; Tobelem G
J Cell Physiol; 1991 Oct; 149(1):50-9. PubMed ID: 1719003
[TBL] [Abstract][Full Text] [Related]
37. Stimulation of endothelial secretion of tissue-type plasminogen activator by repetitive stretch.
Iba T; Shin T; Sonoda T; Rosales O; Sumpio BE
J Surg Res; 1991 May; 50(5):457-60. PubMed ID: 1903823
[TBL] [Abstract][Full Text] [Related]
38. [Levels of tissue-type plasminogen activator and plasminogen activator inhibitor 1 in disseminated intravascular coagulation syndrome].
Fukao H; Yamamoto K; Matsuo O
Rinsho Byori; 1991 Jul; 39(7):720-6. PubMed ID: 1920864
[TBL] [Abstract][Full Text] [Related]
39. Biological mechanisms underlying the clinical effects of RU 486: modulation of cultured endometrial stromal cell plasminogen activator and plasminogen activator inhibitor expression.
Lockwood CJ; Krikun G; Papp C; Aigner S; Schatz F
J Clin Endocrinol Metab; 1995 Apr; 80(4):1100-5. PubMed ID: 7714076
[TBL] [Abstract][Full Text] [Related]
40. Dexamethasone inhibition of tissue-type plasminogen activator (tPA) activity: paradoxical induction of both tPA antigen and plasminogen activator inhibitor.
Gelehrter TD; Sznycer-Laszuk R; Zeheb R; Cwikel BJ
Mol Endocrinol; 1987 Jan; 1(1):97-101. PubMed ID: 3137452
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
